Acute effects of nitric oxide blockade with L-NAME on arterial haemodynamics in rat

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 1237-1243

  Hu, Cheng Tao ^b   Chang, Kuo Chu ^c   Wu, Chia Yen ^a   Chen, Hsing I ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arterial haemodynamics; Arterial hypertension; Arterial impedance; L NAME; Nitric oxide; NO blockade; Vascular resistance

Indexed keywords

AMINOGUANIDINE; ANGIOTENSIN; ARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; AORTA FLOW; AORTA PRESSURE; ARTERY COMPLIANCE; ARTICLE; FOURIER TRANSFORMATION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE;

ANIMALS; ARTERIES; ENZYME INHIBITORS; HEMODYNAMIC PROCESSES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED WKY;

EID: 0030833961     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701496     Document Type: Article

References (46)

1. AMEZCUA, J.L., PALMER, R.M.J., SOUZA, B.M. & MONCADA, S. (1989). Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol., 97, 1119-1124.
2. ARNAL, J.F., EL AMRANI, A.I., CHATELLIER, G., MENARD, J. & MICHEL, J.B. (1993). Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension, 22, 380-387.
3. CHANG, K.C., HSIEH, K.S., KUO, T.S. & CHEN, H.I. (1990). Effects of nifedipine on systemic hydraulic vascular load in patients with hypertension. Cardiovasc. Res., 24, 719-726.
4. CHANG, K.C., TSENG, Y.Z., KUO, T.S. & CHEN, H.I. (1994). Impaired left ventricular relaxation and arterial stiffness in patients with essential hypertension. Clin. Sci., 87, 641-647.
5. CHEN, H.I., HU, C.T. & CHANG, K.C. (1996). Characterization of arterial hemodynamics in rats with established hypertension. Chinese J. Physiol., 39, 49-55.
6. FARACI, F.M. (1991). Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am. J. Physiol., 261, H1038-H1042.
7. G-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br. J. Pharmacol., 102, 823-826.
8. FURCHGOTT, R.F. (1983). Role of endothelium in responses of vascular smooth muscle. Circ. Res., 53, 557-573.
9. FURCHGOTT, R.F. & ZAWADSKI, J. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
10. GARDINER, S.M., COMPTON, A.M., BENNETT, T., PALMER, R.M.J. & MONCADA, S. (1990a). Control of regional blood flow by endothelium-derived nitric oxide. Hypertension, 15, 486-492.
11. G-nitro-L-arginine methyl ester in conscious, Long-Evans rats. Br. J. Pharmacol., 101, 625-631.
12. G-nomomethyl-L-arginine inhibits endothelium-dependent relaxation induced by N-α-benzoyl-L-arginine in rat aorta. In Nitric Oxide from L-Arginine: a Bioregulatory System, ed. Moncada, S. & Higgs, E.A. Amsterdam: Elsevier, pp. 393-395.
13. GRIFFITH, T.M. & EDWARDS, D.H. (1990). Nitric oxide in arterial networks. In Nitric Oxide from L-Arginine: a Bioregulatory System, ed. Moncada, S. & Higgs, E.A. Amsterdam: Elsevier, pp. 397-408.
14. GRIFFITH, T.M., EDWARDS, D.H., DAVIES, R.L., HARRISON, T.J. & EVANS, K.T. (1987). EDRF coordinates the behaviour of vascular resistance vessels. Nature (Lond.), 329, 442-445.
15. GRIFFITHS, M.J.D., MESSENT, M., MACALLISTER, R.J. & EVANS, T.W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmocol., 110, 963-968.
16. GUNDEL, W., CHERRY, G., RAJAGOPALAN, B., TAN, L.B. & SCHULTZ, D. (1981). Aortic input impedance in man: acute response to vasodilator drugs. Circulation, 63, 1305-1314.
17. HU, C.T., CHANG, K.C., KUO, T.S. & CHEN, H.I. (1994). The correlation of cardiac mass with arterial haemodynamics of resistive and capacitive load in rats with normotension and established hypertension. Pflügers Arch. (Eur. J. Physiol.), 428, 533-541.
18. HU, C.T., WU, C.Y. & CHEN, H.I. (1996). Beta-adrenergic mechanism in arterial hemodynamics: a comparison between normotensive and hypertensive rats. J. Biomed. Sci., 3, 286-292.
19. IGNARRO, L.J., BUGA, G.M., WOOD, K.S., BYRNS, R.E. & CHAUDHURI, G. (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl Acad. Sci. U.S.A., 84, 9265-9269.
20. G-nitro-L-arginine and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem. Biophys. Res. Comm., 199, 147-154.
21. G-monomethyl-L-arginine on endothelium-dependent relaxations to vasopressin. In Nitric Oxide From L-Arginine: a Bioregulatory System, ed. Moncada, S. & Higgs, E.A. Amsterdam: Elsevier. pp. 69-72.
22. LEVI, R., GROSS, S.S., LAMPARTER, B., FASEHUM, O.A., AISAKA, K., JAFFE, E.A., GRIFFITH, O.W. & STUEHER, D.J. (1990). Evidence that L-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide. In Nitric Oxide From L-Arginine: a Bioregulatory System, ed. Moncada, S. & Higgs, E.A. Amsterdam: Elsevier. pp. 35-45.
23. LEVY, B.I., BABALIS, D., LACOLLY, P., POITEVEN, P. & SAFAR, M.E. (1988). Cardiac hypertrophy and characteristic impedance in spontaneously hypertensive rats. J. Hypertens., 6 (Suppl. 4), S110-S111.
24. LIU, Z., BRIN, K.P. & YIN, F.C.P. (1986). Estimation of total arterial compliance: an improved method and evaluation of current methods. Am. J. Physiol., 251, H588-H600.
25. MILNOR, W.R. (1975). Arterial impedance as ventricular afterload. Circ. Res., 251, 565-570.
26. MILNOR, W.R. (1989). Hemodynamics, 2nd edn. Baltimore: Williams & Wilkins.
27. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
28. MONCADA, S., RADOMSKI, M.W. & PALMER, R.M.J. (1988). Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function,. Biochem. Pharmacol., 37, 2495-2501.
29. NICHOLS, W.W., CONTI, C.R., WALKER, W.E. & MILNOR, W.R. (1977). Input impedance of the systemic circulation in man. Circ. Res., 40, 451-458.
30. OKAMURA, T., AYAJIKI, K. & TODA, N. (1996). Neural mechanism of pressor action of nitric oxide synthase inhibitor in anesthetized monkeys. Hypertension, 28, 341-346.
31. O'ROURKE, M.F. (1982). Vascular impedance: the relationship between pressure and flow. In Arterial Function in Health and Disease, ed. O'Rourke, M.F., London: Livingstone/Churchill. pp. 94-132.
32. O'ROURKE, M.F. & TAYLOR, M.G. (1967). Input impedance of the systemic circulation. Circ. Res., 20, 365-380.
33. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond.), 327, 524-526.
34. PALMER, R.M.J., REES, D.D., ASHTON, D.S. & MONCADA, S. (1988). L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 153, 1251-1256.
35. PEGORARO, A.A., CARRETERO, O.A., SIGMON, D.H. & BEIERWALTES, W.H. (1992). Sympathetic modulation of endothelium-derived relaxing factor. Hypertension, 19, 643-647.
36. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989). Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A., 86, 3375-3378.
37. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1990a). Nitric oxide and the microcirculation. In Nitric Oxide From L-Arginine: a Bioregulatory System, ed. Moncada, S. & Higgs, E.A. Amsterdam: Elsevier. pp. 427-437.
38. REES, D.D., PALMER, R.M.J., SCHULZ, R., HUDSON, H.F. & MONCADA, S. (1990b). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
39. REES, D.D., SCHULZ, R., HUDSON, H.F., PALMER, R.M.J. & MONCADA, S. (1990c). Identification of some novel inhibitors of the vascular nitric oxide synthase in vivo and in vitro. In Nitric Oxide From L-Arginine: a Bioregulatory System, ed. Moncada, S. & Higgs, E.A., Amsterdam: Elsevier. pp. 485-487.
40. G-monomethyl-L-arginine is a non-specific inhibitor of vascular relaxation. Eur. J. Pharmacol., 170, 123-124.
41. WANG, D., HSU, K., HWANG, C.P. & CHEN, H.I. (1995). Measurement of nitric oxide release in the isolated perfused rat lung. Biochem. Biophys. Res. Commun., 208, 1016-1020.
42. WARD, J.E. & ANGUS, J.A. (1993). Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. J. Cardiovasc. Pharmacol., 21, 804-814.
43. WESTERHOF, N., SIPKEMA, P., VAN DEN BOS, G.C. & ELZINGA, G. (1972). Forward and backward waves in the arterial system. Cardiovasc. Res., 6, 648-656.
44. YIN, F.C.P., GUZMAN, P.A., BRIN, K.P., MAUGHAN, W.L., BRINKER, J.A., TRAILL, T.A., WEISS, J.L. & WEISFELDT M.L. (1983). Effect of nitroprusside on hydraulic vascular loads on the right and left ventricle of patients with heart failure. Circulation, 67, 1330-1339.
45. YOSHIDA, K., OKAMURA, T., KIMURA, H., BREDT, D.S., SNYDER, S.H. & TODA, N. (1993). Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries. Brain Res., 629, 67-72.
46. ZUCKERMAN, B.D. & YIN, F.C.P. (1989). Aortic impedance and compliance in hypertensive rats. Am. J. Physiol., 257 (Heart Circ. Physiol. 26), H553-H562.